SV

Shweta Vijendra Chaule

Active Director Director DIN 11132912
DIN 11132912 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shweta Vijendra Chaule

Data last updated:

Shweta Vijendra Chaule is a Director at Vidhyaishwar Healthcare And Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11132912
Primary Designation Director
Industry Pharma
First Appointment 30 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20252025Active

Directorship timeline

Open interactive timeline →
Vidhyaishwar Healthcare And Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shweta Vijendra Chaule

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shweta Vijendra Chaule

Shweta Vijendra Chaule currently holds 1 directorship: Vidhyaishwar Healthcare And Pharmaceuticals Private Limited (Director, since 30 May 2025).

Shweta Vijendra Chaule was first appointed on 30 May 2025 as Director at Vidhyaishwar Healthcare And Pharmaceuticals Private Limited.

The current boards of Shweta Vijendra Chaule's companies include Ishwar Laxman Gajbhiye (Vidhyaishwar Healthcare And Pharmaceuticals Private Limited), Prashant Vasantrao Misar (Vidhyaishwar Healthcare And Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available